Effects of typheramide and alfrutamide found in Allium species on cyclooxygenases and lipoxygenases

Journal of Medicinal Food

Volumn 14, Issue 3, 2011, Pages 226-231

  Park, Jae B ^a  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

alfrutamide; Allium fistulosum (green onion); Allium sativum (garlic); cyclooxygenase inhibition; lipoxygenase; typheramide

Indexed keywords

ACETYLSALICYLIC ACID; ALFRUTAMIDE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GARLIC EXTRACT; NS 296; ONION EXTRACT; PROSTAGLANDIN SYNTHASE INHIBITOR; TYPHERAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; FRACTIONATION; GARLIC; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; WELSH ONION;

ALLIUM; CAFFEIC ACIDS; COUMARIC ACIDS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; HUMANS; LIPOXYGENASES; PLANT EXTRACTS; TYRAMINE;

ALLIUM; ALLIUM CEPA; ALLIUM FISTULOSUM; ALLIUM SATIVUM;

EID: 79951971419     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.0198     Document Type: Article

References (31)

1. Jenkins CM, Cedars A, Gross RW: Eicosanoid signalling pathways in the heart. Cardiovasc Res 2009;82:240-249.
2. Skelly MM, Hawkey CJ: COX-LOX inhibition: current evidence for an emerging new therapy. Int J Clin Pract 2003;57:301-304. (Pubitemid 36700715)
3. Celotti F, Laufer S: Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept. Pharmacol Res 2001;43:429-436. (Pubitemid 32578858)
4. Leone S, Ottani A, Bertolini A: Dual acting anti-inflammatory drugs. Curr Top Med Chem 2007;7:265-275. (Pubitemid 46358660)
5. Fiorucci S, Meli R, Bucci M, Cirino G: Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem Pharmacol 2001;62:1433-1438.
6. Kozak W, Fraifeld V: Non-prostaglandin eicosanoids in fever and anapyrexia. Front Biosci 2004;9:3339-3355.
7. Poff CD, Balazy M: Drugs that target lipoxygenases and leukotrienes as emerging therapies for asthma and cancer. Curr Drug Targets Inflamm Allergy 2004;3:19-33. (Pubitemid 38854887)
8. Imig JD: Eicosanoids and renal vascular function in diseases. Clin Sci 2006;111:21-34.
9. Guilemany JM, Roca-Ferrer J, Mullol J: Cyclooxygenases and the pathogenesis of chronic rhinosinusitis and nasal polyposis. Curr Allergy Asthma Rep 2008;8:219-226.
10. Manev H, Uz T, Sugaya K, Qu T: Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J 2000;14:1464-1469. (Pubitemid 30439756)
11. Hikiji H, Takato T, Shimizu T, Ishii S: The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. Prog Lipid Res 2008;47:107-126.
12. Kuhn H, Walther M, Kuban RJ: Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. Prostaglandins Other Lipid Mediat 2002;68-69:263-290. (Pubitemid 35247401)
13. Liagre B, Vergne P, Rigaud M, Beneytout JL: Arachidonate 15-lipoxygenase of reticulocyte-type in human rheumatoid arthritis type B synoviocytes and modulation of its activity by proinflammatory cytokines. J Rheumatol 1999;26:1044-1051. (Pubitemid 29215066)
14. Moreno JJ: New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem Pharmacol 2009;77:1-10.
15. Leone S, Ottani A, Bertolini A: Dual acting anti-inflammatory drugs. Curr Top Med Chem 2007;7:265-275. (Pubitemid 46358660)
16. Rivlin RS: Historical perspective on the use of garlic. J Nutr 2001;131(3s):951S-954S.
17. Banerjee SK, Mukherjee PK, Maulik SK: Garlic as an antioxidant: the good, the bad and the ugly. Phytother Res 2003;17:97-106. (Pubitemid 36262255)
18. Chen JH, Tsai SJ, Chen HI: Welsh onion (Allium fistulosum L.) extracts alter vascular responses in rat aortae. J Cardiovasc Pharmacol 1999;33:515-520.
19. Rahman K, Lowe GM: Garlic and cardiovascular disease: a critical review. J Nutr 2006;136(3 Suppl):736S-740S.
20. Lau BH: Suppression of LDL oxidation by garlic. J Nutr 2001;131(3s):985S-988S.
21. Devrim E, Durak I: Is garlic a promising food for benign prostatic hyperplasia and prostate cancer? Mol Nutr Food Res 2007;51:1319-1323.
22. Gorinstein S, Jastrzebski Z, Namiesnik J, Leontowicz H, Leontowicz M, Trakhtenberg S: The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Mol Nutr Food Res 2007;51:1365-1381. (Pubitemid 350195610)
23. Rahman K: Historical perspective on garlic and cardiovascular disease. J Nutr 2001;131(3s):977S-979S.
24. Park JB, Schoene N: Clovamide-type phenylpropenoic acid amides, N-coumaroyldopamine and N-caffeoyldopamine, inhibit platelet-leukocyte interactions via suppressing P-selectin expression. J Pharmacol Exp Ther 2006;317:813-819.
25. Faraday N, Becker DM, Becker LC: Pharmacogenomics of platelet responsiveness to aspirin. Pharmacogenomics 2007;8:1413-1425. (Pubitemid 350162853)
26. Wu KK: Control of COX-2 and iNOS gene expressions by aspirin and salicylate. Thromb Res 2003;110:273-276.
27. Huang LS, Kang JS, Kim MR, Sok DE: Oxygenation of arachidonoyl lysophospholipids by lipoxygenases from soybean, porcine leukocyte, or rabbit reticulocyte. J Agric Food Chem 2008;56:1224-1232.
28. Hayashi S, Gresshoff PM, Kinkema M: Molecular analysis of lipoxygenases associated with nodule development in soybean. Mol Plant Microbe Interact 2008;21:843-853. (Pubitemid 351929178)
29. Wittwer J, Hersberger M: The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007;77:67-77. (Pubitemid 47539103)
30. Kühn H, O'Donnell VB: Inflammation and immune regulation by 12=15-lipoxygenases. Prog Lipid Res 2006;45:334-356.
31. 4 in allergic diseases. Allergol Int 2008;57:291-298.